Peg-intron and Sonata drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Peg-intron (peginterferon alfa-2b) and Sonata (zaleplon). Common drug interactions include poor quality sleep among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Peg-intron and Sonata. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Peg-intron?

Peg-intron has active ingredients of peginterferon alfa-2b. eHealthMe is studying from 11,142 Peg-intron users. Check the latest studies of Peg-intron.

What is Sonata?

Sonata has active ingredients of zaleplon. It is often used in insomnia. eHealthMe is studying from 3,330 Sonata users. Check the latest studies of Sonata.

On Jul, 20, 2026

16 people who take Peg-intron and Sonata together, and have interactions are studied.

Peg-intron and Sonata drug interactions.

What are the common drug interactions of Peg-Intron and Sonata, by gender? *:

female:

Poor quality sleep
Rash macular (small, flat red spots)
Abscess (pus)
Activities of daily living impaired
Blood calcium decreased
Erythema (redness of the skin)
Hypokalaemia (low potassium)
Intervertebral disc disorder (spinal disc disorder)
Muscle strain (an injury to a muscle in which the muscle fibres tear)
Swollen tongue (swelling of tongue)

male:

Anaemia (lack of blood)
Blood pressure increased
Tachycardia (a heart rate that exceeds the range of 100 beats/min)
Tremor (trembling or shaking movements in one or more parts of your body)
Completed suicide (act of taking one's own life)
Dysphemia (stammering or stuttering)
Hypomania (a mild form of mania, marked by elation and hyperactivity)
Intestinal ischaemia (decreased supply of oxygenated blood to the intestines)
Mania (a state of abnormally elevated or irritable mood)
Overdose

What are the common drug interactions of Peg-Intron and Sonata, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Anaemia (lack of blood)
Renal cell carcinoma stage unspecified (kidney cancer in unknown stage)

10-19:

n/a

20-29:

Hyperthyroidism (over activity of the thyroid gland)
Thyroid disorder (thyroid diseases)
Weight decreased

30-39:

n/a

40-49:

Fatigue (feeling of tiredness)
Fibromyalgia (a long-term condition which causes pain all over the body)
Hypoaesthesia (reduced sense of touch or sensation)
Joint swelling
Memory impairment
Neuropathy (damage to nerves)
Poor quality sleep
Rash macular (small, flat red spots)
Abscess (pus)
Activities of daily living impaired

50-59:

Anaemia (lack of blood)
Dysgeusia (disorder of the sense of taste)
White blood cell count decreased
Asthenia (weakness)
Dyspnoea (difficult or laboured respiration)
Dyspnoea exertional (breathlessness or shortness of breath)
Intestinal ischaemia (decreased supply of oxygenated blood to the intestines)
Middle insomnia (difficulty returning to sleep after awakening either in the middle of the night)
Muscular weakness (muscle weakness)
Oral pain

60+:

n/a

What are the existing conditions these people have? *

Hepatitis C: 16 people, 100.00%
Stress And Anxiety: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Peg-intron and Sonata?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously